BibTex RIS Cite

ECMO Setinde Heparin Nötralizasyonu

Year 2017, Volume: 11 Issue: 2, 151 - 152, 01.06.2017

References

  • Firmin RK, Killer HM. Extracorporeal membrane oxygenation. Perfusion 1999;14:291-7.
  • Rais-Bahrami K, Short BL. The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000;24:406-17.
  • Lustbader D, Fein A. Other modalities of oxygen therapy. Respir Care Clin N Am 2000;6:659-74.
  • Peek GJ, Sosnowski AW. Extracorporeal membrane oxygenation for paediatric respiratory failure. Bri Med Bull 1997;53:745-56.
  • Beghetti M, Rimersberger PC. Mechanical circulatory support in pediatric patients. Intensive Care Med 2000;26: 350-2.
  • Dickey LA, Butler TJ, Bergmann TM, Bates ME, Null DM. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in short-term pig model. Perfusion 1994;9:327-33.
  • Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996;61:330-5.
  • Ray MJ, Hales MM, Brown L, O’Brien MF, Stafford EG. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001;72:521-6.
  • Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 1999;45:250-63.
  • Yang VC, Port FK, Kim JS, Teng CL, Till GO, Wakefield TW. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-97.
  • Boigner H, Lechner E, Brock H, Golej J, Trittenwein G. Life threatening cardiopulmonary failure following protamine reversal of heparin after cardiopulmonary bypass. Paediatr Anaesth 2001;11:729-32.
  • Malviya S. Monitoring and management of anticoagulation in children requiring extracorporeal circulation. Semin Thromb Hemost 1997;23:563-7.
  • Mikhailidis DP. Regarding ‘heparin modulates integrin function in human platelets’. J Vasc Surg 2002;35:405-6.
  • Greenbaum RA, Barradas MA, Mikhailidis DR, Jeremy JY, Evans TR, Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res 1987;21:878-85.
  • Sugimoto M, Miyata S. Functional property of von Willebrand factor under flowing blood. Int J Hematol 2002;75:19-24.

Neutralization of Heparin for Extracorporeal Membrane Oxygenation

Year 2017, Volume: 11 Issue: 2, 151 - 152, 01.06.2017

References

  • Firmin RK, Killer HM. Extracorporeal membrane oxygenation. Perfusion 1999;14:291-7.
  • Rais-Bahrami K, Short BL. The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000;24:406-17.
  • Lustbader D, Fein A. Other modalities of oxygen therapy. Respir Care Clin N Am 2000;6:659-74.
  • Peek GJ, Sosnowski AW. Extracorporeal membrane oxygenation for paediatric respiratory failure. Bri Med Bull 1997;53:745-56.
  • Beghetti M, Rimersberger PC. Mechanical circulatory support in pediatric patients. Intensive Care Med 2000;26: 350-2.
  • Dickey LA, Butler TJ, Bergmann TM, Bates ME, Null DM. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in short-term pig model. Perfusion 1994;9:327-33.
  • Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996;61:330-5.
  • Ray MJ, Hales MM, Brown L, O’Brien MF, Stafford EG. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001;72:521-6.
  • Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 1999;45:250-63.
  • Yang VC, Port FK, Kim JS, Teng CL, Till GO, Wakefield TW. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 1991;75:288-97.
  • Boigner H, Lechner E, Brock H, Golej J, Trittenwein G. Life threatening cardiopulmonary failure following protamine reversal of heparin after cardiopulmonary bypass. Paediatr Anaesth 2001;11:729-32.
  • Malviya S. Monitoring and management of anticoagulation in children requiring extracorporeal circulation. Semin Thromb Hemost 1997;23:563-7.
  • Mikhailidis DP. Regarding ‘heparin modulates integrin function in human platelets’. J Vasc Surg 2002;35:405-6.
  • Greenbaum RA, Barradas MA, Mikhailidis DR, Jeremy JY, Evans TR, Dandona P. Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res 1987;21:878-85.
  • Sugimoto M, Miyata S. Functional property of von Willebrand factor under flowing blood. Int J Hematol 2002;75:19-24.
There are 15 citations in total.

Details

Other ID JA95CN55GB
Journal Section Letter to Editor
Authors

Benan Bayrakçı This is me

Publication Date June 1, 2017
Submission Date June 1, 2017
Published in Issue Year 2017 Volume: 11 Issue: 2

Cite

Vancouver Bayrakçı B. Neutralization of Heparin for Extracorporeal Membrane Oxygenation. Türkiye Çocuk Hast Derg. 2017;11(2):151-2.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.